Signing for deliveries of controlled drugs and
other medicines
There have been some issues raised in respect of
the signing for controlled drugs and other medicines.
Please find attached a letter sent from Mr Canice
Ward to the Northern Ireland wholesale dealers, which helpfully recognises that
in the current situation it may be necessary to deviate from the normal
procedure in respect of signing for deliveries of medicines.
The guidance indicates that it would be acceptable
if alternative arrangements are implemented for the signing for orders
(including those for controlled drugs), provided these interim measures can
verify that the products have been delivered.
Action
Contractors should:
Make their dispensary teams aware of this advice.
CPNI will continue to advise and support you in the
weeks to come.
Yours
sincerely
Mike
Sent
on behalf of Prof Mike Mawhinney| Head
of Regulatory Affairs
Download
Dear Colleague,
Letter from Cathy Harrison, CPO to Contractors re: COVID-19
Please see the attached letter from Cathy Harrison.
Do not hesitate to contact CPNI office or your local CPNI
director if you require any additional information.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear Colleague
Please find attached Guidance issued by Professor Stephen Powis,
NHS England Medical Director in relation to the use of Non-Steroidal
Anti-Inflammatory Medications and COVID-19.
Please ensure that the alert notification is shared with all
relevant staff in the Pharmacy(-ies) you operate.
Thank-you.
Vanessa
SENT FOR AND BEHALF OF DR. VANESSA CHAMBERS | Head of Policy & Pharmacy Development
Download
+++ Sent to Contractors in Belfast LCG Area Only +++
Dear Colleague
Infant formula: measures to minimise stockpiling
Joe Brogan, HSCB, has asked CPNI to share the following
information with Belfast Contractors.
HSCB has been alerted by Belfast HSCT midwives of shortages in
infant formula in pharmacies across the city. HSCB has confirmed with suppliers
that there is no supply shortage currently however, if stockpiling
becomes widespread, there is a potential for shortages to emerge.
Rather than raise this issue with the general public and
inadvertently create more panic buying, community pharmacists are asked to
consider measures to ensure stockpiling is minimised, for example, by
restricting the number permitted to be purchased.
Pharmacists are also asked to continue to exercise the same
controls in respect of all over-the-counter medicines.
Action
Contractors are asked to cascade this to your pharmacy team members who are involved in the ordering and sale of infant formula and of any other products that may be affected by supply issues.
CPNI will continue to advise and support you in the weeks to
come.
Yours sincerely
SENT FOR AND BEHALF
OF GERARD GREENE | Chief Executive
Dear Colleague,
COVID-19 transmission; information needed on isolation rates
CPNI is working with the DH and with HSCB to establish an urgent
route for community pharmacists and their teams to have access to COVID
testing.
It is important that there are up-to-date figures relating to
the numbers of staff within community pharmacy who are self-isolating.
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
COVID-19 Community Pharmacy Posters.
We continue to work with HSCB, PHA & DoH(NI) in order to
provide you and your teams with support, resources and information throughout
this extremely challenging period.
Public messaging is an extremely important way of raising
awareness of how to reduce the risk of transmission of COVID-19 to the public
and/or your staff. All pharmacies will receive the attached letter and
Pharmacy COVID-19 Advice posters by post shortly.
Please ensure that these posters are displayed prominently at
the entrance(s) to your pharmacy. I have attached an electronic version
of the Community Pharmacy Stop the Spread poster so that additional
copies can be printed off and displayed immediately throughout your pharmacy
until such times that the larger posters arrive in the post.
Please ensure that you forward this email on to all relevant
pharmacy leads within your team, encouraging them to display the posters when
they are received.
Should you require additional copies please do not hesitate to
contact your local HSCB offices.
Thank-you.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.